This method of BA participation is achieved by decreasing the expression of the FXR receptor, which in turn reduces blood glucose levels by increasing the secretion of GLP-1, thereby effectively controlling the progression of T2DM (Figure 5). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.